Nasdaq nstg.

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022. “We are thrilled with the momentum that’s building in the spatial biology market.Expanded nCounter® Instrument Product Line Expected to Reach Deeper Into Cancer Research Market. SEATTLE, July 15, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider ...NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5%SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced an update to the technology roadmap for the CosMx™ Spatial Molecular Imager (SMI) that will be presented at the 2023 Advances in Genome Biology and …Nov 16, 2023 · "NanoString Technologies, Inc. (NASDAQ:NSTG): NSTG is a leader in spatial biology, offering a platform of products that help researchers map biology down to a single-cell. Since our purchase of ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation against NanoString Technologies, Inc. (Nasdaq ...

SEATTLE, March 01, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is ...

Dec 1, 2023 · Stock analysis for NanoString Technologies Inc (NSTG:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. If you’re familiar with investing, then you’ve probably heard of major stock exchanges like the New York Stock Exchange or the NASDAQ. Stock exchanges are sort of like a mixture between an auction house and a marketplace where investors can...SEATTLE, Sept. 9, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, ...Below is a chart showing NSTG's trailing twelve month trading history, with the $10 strike highlighted in orange: Cisco Systems Inc (Symbol: CSCO) options are showing a volume of 97,085 contracts ...

SEATTLE, Sept. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

SEATTLE, Oct. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

Nanostring Technologies (NASDAQ: NSTG) is owned by 102.08% institutional shareholders, 56.27% Nanostring Technologies insiders, and 0.00% retail investors. Clarus Lifesciences Ii LP is the largest individual Nanostring Technologies shareholder, owning 6.07M shares representing 12.62% of the company.Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.A. The latest price target for NanoString Technologies ( NASDAQ: NSTG) was reported by Baird on Tuesday, November 21, 2023. The analyst firm set a price target for 0.75 expecting NSTG to rise to ...Fintel reports that on November 21, 2023, Baird downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Outperform to Neutral . Analyst Price Forecast Suggests 1,436.84% Upside As ...May 4, 2023 · NanoString Technologies, Inc. (NASDAQ:NASDAQ:NSTG) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ETCompany ParticipantsDoug Farrell – Vice President,... Business Wire - Wed Mar 8, 3:00PM CST. NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today …Ablynx (OTCMKTS:ABLYF – Get Free Report) and NanoString Technologies (NASDAQ:NSTG – Get Free Report) are both medical companies, but which is the …

SEATTLE, May 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported ...As of August 1, 2023, the average one-year price target for Nanostring Technologies is 16.76. The forecasts range from a low of 13.13 to a high of $25.20. The average price target represents an ...Below is a chart showing NSTG's trailing twelve month trading history, with the $10 strike highlighted in orange: Cisco Systems Inc (Symbol: CSCO) options are showing a volume of 97,085 contracts ...Nov 15, 2023 · The NSTG stock price is -964.52% off its 52-week high price of $13.20 and 17.74% above the 52-week low of $1.02. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.09 million shares traded. The 3-month trading volume is 1.44 million shares. Nanostring Technologies Inc (NASDAQ:NSTG) trade information NanoString Technologies Stock Performance. Shares of NSTG opened at $1.24 on Monday. The company has a current ratio of 3.55, a quick ratio of 2.76 and a debt-to-equity ratio of 16.67. The company ...NanoString Technologies, Inc. (NASDAQ:NSTG) shareholders should be happy to see the share price up 27% in the last month.But that's not enough to compensate for the decline over the last twelve monthsAs of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.

SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...NanoString Technologies Stock Performance. NASDAQ NSTG opened at $0.56 on Monday. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73.

In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021. Financial Statements.Ablynx (OTCMKTS:ABLYF – Get Free Report) and NanoString Technologies (NASDAQ:NSTG – Get Free Report) are both medical companies, but which is the …SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for the second quarter ended June 30, 2023. “We are excited to report that our teams delivered strong …NSTG's stock price has decreased by -92.21% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 5 stock analysts, the average 12-month stock price forecast for NSTG stock stock is $2.83, which predicts an increase of 410.46%.NanoString Technologies, Inc. (NASDAQ:NSTG) shares were also up, gaining 37% to $5.06 after the company said it expects second-quarter revenue to be over $44 million, above the upper end of its ...Find the latest SEC Filings data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com. Shares of NanoString Technologies ( NSTG -1.37%) were down more than 16% Thursday morning and were down as much as 28.3% earlier in the day after the life sciences company lost a patent ruling in ...Nov 30, 2023 · In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021. Financial Statements. JP Morgan has downgraded NanoString ( NASDAQ: NSTG) to neutral due to limited near-term visibility amid ongoing patent litigation. The investment bank noted that NanoString is embroiled in ongoing ...PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...

NanoString Technologies Stock Performance. Shares of NSTG opened at $1.24 on Monday. The company has a current ratio of 3.55, a quick ratio of 2.76 and a debt-to-equity ratio of 16.67. The company ...

21 Nov 2023 ... Baird downgraded NanoString (NASDAQ:NSTG) from Buy to Neutral on Tuesday after the life sciences company withdrew its guidance following a ...

Feb 28, 2023 · NanoString Technologies (NSTG) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.64 per share a year ago. Nov 24, 2023 · Nanostring Technologies Inc (NASDAQ:NSTG)’s traded shares stood at 2.26 million during the latest session, with the company’s beta value hitting 1.34. At the last check today, the stock’s price was $0.57, to imply an increase of 9.24% or $0.05 in intraday trading. The NSTG share’s 52-week ... Nov 7, 2023 · NanoString Technologies, Inc. (NASDAQ:NSTG) Q3 2023 Earnings Call Transcript. Published on November 7, 2023 at 10:52 am by Insider Monkey Transcripts in News, Transcripts. So if you really – if ... The worst performers were NanoString Technologies Inc (NASDAQ: NSTG) which was down 33.63% to 21.87 in late trade, Polarityte Inc (NASDAQ: PTE) which lost 30.84% to settle at 0.27 and Crown ...NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43 rd Annual Cowen Health Care …Hedge Funds Are Piling Into NanoString Technologies Inc (NSTG) Top 5 Stock Picks of Efrem Kamen's Pura Vida Investments NanoString Technologies, Inc. (NASDAQ:NSTG) Q1 2023 Earnings Call Transcript ...NanoString Technologies, Inc. (NASDAQ:NSTG) shares fell 46% to $0.69. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.Dec 4, 2023 · NanoString Technologies Stock Performance. NASDAQ NSTG opened at $0.56 on Monday. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73. NanoString Technologies last posted its earnings results on November 6th, 2023. The biotechnology company reported ($0.78) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by $0.25. The company had revenue of $48.09 million for the quarter, compared to analyst estimates of $46.05 million.Oct 10, 2023 · The company will release Q3 FY23 results on November 6, 2023. Price Action: NSTG shares are up by 10.0% at $1.32 premarket on the last check Tuesday. NanoString Technologies Inc (NASDAQ:NSTG ... SEATTLE, March 08, 2023--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq ...

"NanoString Technologies, Inc. (NASDAQ:NSTG): NSTG is a leader in spatial biology, offering a platform of products that help researchers map biology down to a single-cell. Since our purchase of NSTG at the inception of the strategy nearly five years ago, the company has significantly widened its technology platform and products, …Nov 3, 2023 · Nanostring Technologies Inc (NASDAQ:NSTG)’s traded shares stood at 1.12 million during the last session, with the company’s beta value hitting 1.66. At the close of trading, the stock’s price was $1.41, to imply an increase of 4.44% or $0.06 in intraday trading. The NSTG share’s 52-week high ... (NASDAQ: NSTG) Nanostring Technologies's 52-week high was $13.20, and its 52-week low was $0.47. It is currently -96.03% from its 52-week high and 11.25% from its 52-week …Instagram:https://instagram. best investing magazineshighest fixed annuity ratesmy dividend trackerstock options trading brokers SEATTLE, March 01, 2023--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is ...SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ... jepi marketwatchday trade apps SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the fourth quarter and fiscal year ended December 31, 2022. “We are thrilled with the momentum that’s building in the spatial biology market. dlp lending fund Founded in 2003, NanoString’s (NASDAQ:NSTG) nCounter technology is a variant on the DNA microarray. As of the first quarter of 2022, Kamen’s Pura Vida Investments owns more than 1.2 million ...NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported prelimi